Please select the eligibility criteria that correspond to the clinical trial below.
Title: A Structured Multidisciplinary Intervention to Improve Quality of Life of Patients Receiving Active Oncological Treatment: A Randomized Trial
Brief Summary: This randomized clinical trial studies structured multidisciplinary intervention or standard medical care in improving quality of life (QOL) in patients receiving active cancer treatment. A structured multidisciplinary intervention may improve the QOL in patients receiving treatment for cancer. It is not yet known whether structured multidisciplinary intervention is more effective than standard medical care in improving QOL


Options:
A: Inclusion Criteria:

* solitary or multiple vertebral metastases
* thoracic spine
* lumbar spine
* sacrum
* indication for palliative radiation therapy
* age: 18 - 80 years
* Karnofsky index \> 70%
* bisphosphonate therapy inititated

Exclusion Criteria:

* bony metastases of cervical spine or pelvis
* impending fracture
* other serious illnesses or medical conditions: therapy-refractory unstable heart disease, congestive heart failure NYHA °III and °IV; coagulopathies
* Significant neurological or psychiatric condition including dementia or seizures or other serious medical condition prohibiting the patient's participation in the trial by judgement of the investigators
* Legal incapacity or limited legal capacity
* Positive serum/ urine beta-HCG/ pregnancy
B: Inclusion Criteria:

- Having been diagnosed with unilateral breast cancer and having been submitted to surgical and radiation treatment as part of the treatment for breast cancer, according to the therapeutic protocol of the unit

Exclusion Criteria:

- Patients with neurological or orthopedic diseases that could impair the movements of the upper limbs, bilateral breast cancer, previous thoracic radiotherapy, and the presence of distant metastasis.
C: Inclusion Criteria:

* Ability to attend all treatment sessions and follow-up
* Ability to provide written informed consent
* Ability to participate in all aspects of the study
* Initial diagnosis of cancer must have been =\< 12 months prior to study entry
* Intermediate to poor prognosis, defined as an expected 5-year survival of 0-50% in the judgment of the physicians entering the patient on the study
* Eastern Cooperative Oncology Group (ECOG) Performance Status (PS) 0, 1, or 2
* \>= 1 week of planned cancer treatment at Mayo Clinic
* Has a caregiver also willing to participate

Exclusion Criteria:

* Mini-mental state examination (MMSE) scores of \< 20
* Expected survival of \< 6 months
* Active substance abuse (alcohol or drug)
* Participation in other psycho-social research trials
* Active thought disorder (bipolar illness, schizophrenia, etc.)
* Suicidal intent or plan
* In need of psychiatric hospitalization
* Recurrent disease after disease-free interval of \> 6 months
* Previous cancer =\< 5 years (except non-melanoma skin cancer and/or second cancer diagnosed at approximately the same time as this cancer)
D: Inclusion Criteria:

* Histological proven cancer in one or more of the following areas: larynx, hypopharynx, oropharynx, cavi oris, or unknown primary tumor
* Set to curative radiotherapy with or without concurrent chemotherapy for treatment of cancer in the head and neck region in accordance with the Danish Head and Neck Cancer Group (DAHANCA) guidelines
* Fully self-reliant
* Danish skills, oral and written
* Informed consent

Exclusion Criteria:

* Previously received treatment for head and neck cancer (radiotherapy, chemotherapy and/or surgery).
* Pregnancy
* ECOG performance status \> 2
* Presence of psychological-, family-, sociological- or geographical issues that could prevent the patient from completing the intervention
* Simultaneous or previous illness or conditions that could prevent the patient's ability to complete the intervention.

Answer: C